Genetic Technologies (GENE) has released an update.
Genetic Technologies has successfully secured a $2 million investment through a private placement of shares to sophisticated US investors, facilitated by HCW Wainwright & Co. The placement occurred without the need for public disclosure in compliance with the Corporations Act, indicating the company’s adherence to regulatory requirements.
For further insights into GENE stock, check out TipRanks’ Stock Analysis page.
